Something Evil This Way Comes

Hope for a reliable, early detection test

Phase III evaluations have begun on a blood test developed by
researchers out of the Yale School of Medicine. So far the test has
detected newly diagnosed ovarian cancer with 99.4 percent accuracy by
using six protein biomarkers. “We hope this test will become the
standard of care for women having routine examinations,” says lead
author Gil Mor, M.D., associate professor at the department of
Obstetrics, Gynecology and Reproductive Sciences at Yale.

The test requires further study and extended follow-up with more
patients, however the news represents an encouraging development in the
search for a reliable, early detection test for ovarian cancer. Results
from the phase II clinical trials were published in the February 15
issue of the journal Clinical Cancer Research.

This entry was posted on Friday, February 22nd, 2008 at 8:09 pm and is filed under Cancer News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.